Market Overview

Markets are rebounding Monday with SPY +0.4% pre-bell as chip stocks recover from last week’s tech-led selloff. Geopolitical risk remains elevated after Iran launched missiles at Israel over the weekend, though Trump’s comments appear to be calming markets. Emerging markets continue to massively outperform (XCEM +38% YTD vs. SPY +11%), while healthcare is being reframed as a value sector after years of underperformance.

Top Movers

GIII (+10.61%) — $35.58 → $39.50 (+11.0% upside) Thesis: Q1 earnings beat with gross margin expansion driving a raised full-year profit outlook, plus the Marc Jacobs acquisition shifts the portfolio toward higher-margin owned brands. RSI at 15.33 screams deeply oversold — this is a bounce off extreme pessimism with a genuine fundamental catalyst (earnings + M&A), not just a dead cat bounce. The stock had been beaten down heavily and is now repricing to reflect the improved margin trajectory. Levels: Exit at $39.50 (prior resistance area pre-selloff). Support at $32.50 (recent lows).

OSCR (+6.57%) — $25.85 → $29.00 (+12.2% upside) Thesis: Wells Fargo upgrade with PT raised to $20 (already surpassed — suggesting further upgrades incoming), plus leadership transition positioning Mario Schlosser as AI/digital health advisor signals strategic maturity. RSI at 67.7 is approaching overbought but not there yet, and the +12.56% weekly move shows real momentum. The analyst upgrade after Q1 beat gives this legs, but I’d want to see consolidation before adding size. Levels: Exit at $29.00 (round number resistance + extension target). Support at $23.00 (20-day MA area).

ETR (+5.89%) — $110.24 → $119.00 (+7.9% upside) Thesis: Barclays reiterated Overweight with $119 PT, and Entergy’s data center buildout story is a secular tailwind as AI infrastructure spending accelerates across the southern U.S. This is a “picks and shovels” play on the AI theme through power generation — less crowded than buying NVDA. JP Morgan also has it on their June Focus List. Utility with a growth story is rare. Levels: Exit at $119.00 (Barclays PT). Support at $104.00 (prior consolidation zone).

VSXY (+5.66%) — $77.25 → $85.00 (+10.0% upside) Thesis: Blockbuster Q1 with double-digit revenue growth under CEO Hillary Super’s brand turnaround — pricing power restored, discounting reined in, “sexy” image revival working. The +42.27% weekly move is extraordinary and driven by a massive earnings beat plus raised guidance, triggering what appears to be a short squeeze. RSI at 38.51 is actually moderate despite the parabolic move, suggesting this hasn’t fully re-rated yet. However, Wall Street analysts are already calling the excitement “overdone” — proceed with caution. Levels: Exit at $85.00 (psychological resistance). Support at $65.00 (pre-earnings gap level).

VOYA (+4.14%) — $88.64 → $95.00 (+7.2% upside) Thesis: Activist Toms Capital is pushing for a strategic review including a possible full company sale — this is the strongest catalyst type for financial services names. RSI at 12.5 is absurdly oversold, meaning the stock was hated before the activist showed up. Activist + oversold + potential sale = textbook setup. The stock just hit new highs on Friday despite market weakness, confirming institutional accumulation. Levels: Exit at $95.00 (activist-implied fair value zone). Support at $84.00 (breakout level).

CNK (+3.77%) — $31.53 → $34.50 (+9.4% upside) Thesis: Record May domestic box office performance with highest-ever food & beverage spend per guest — this is real operational momentum, not just a good movie slate. B. Riley sees continued domestic box office momentum into June. RSI at 68.9 is nearing overbought, so I’d buy on any intraday pullback rather than chasing. The movie theater recovery is real and CNK is the best-run operator. Levels: Exit at $34.50 (prior 52-week resistance area). Support at $30.00 (round number + recent consolidation).

ARCB (+2.65%) — $158.90 → $175.00 (+10.1% upside) Thesis: Raised Q2 operating income outlook for both LTL and asset-light segments, plus new ArcBest View digital logistics platform launch. Freight recovery is a cyclical trade finally getting confirmation — raised guidance mid-quarter is a high-conviction signal. The +12.86% weekly move reflects the market catching on. Levels: Exit at $175.00 (pre-downturn resistance). Support at $145.00 (gap fill level).

SFM (+2.13%) — $84.58 → $92.00 (+8.8% upside) Thesis: New England expansion with ~150 approved locations is a genuine unit growth story (~8% store count growth in 2026), and the RSI at 4.61 is the most oversold reading on this entire list — this stock has been absolutely destroyed despite strong fundamentals. This looks like capitulation selling meeting a real growth story. Risk is Kroger’s price war pressuring comps. Levels: Exit at $92.00 (prior support-turned-resistance). Support at $80.00 (current floor).

Headlines to Watch

  • Iran attacks Israel with missiles; Trump comments calm markets — Geopolitical escalation could reverse quickly if diplomacy fails; defense stocks and oil benefit, growth names suffer. Watch oil approaching $98/barrel for inflation implications.
  • Chip stocks rebounding pre-bell after last week’s selloff — MU, MRVL, AVGO all WSB favorites; the dip-buying playbook is active but Fed rate hike speculation still lingers.
  • Emerging markets (XCEM) up 38% YTD crushing the S&P — Dollar weakness and ex-China positioning are driving massive outperformance; this rotation has legs if the dollar stays weak.
  • Mizuho reframes healthcare as a value sector — After years of underperformance vs. tech, pharma stocks are attracting value-rotation capital. OSCR’s move today fits this narrative.
  • Goldman Sachs targets S&P 500 at 8,000 year-end — Bullish consensus is building; historically this level of optimism precedes consolidation, not crashes. Stay long but hedge.
  • SpaceX IPO valued at $1.75 trillion approaching — Massive liquidity event could pull capital from public markets temporarily; watch for related space/defense names to benefit from attention.
  • Lithium ETF (LIT) up 125% from last year’s low — Commodity cycle rotation is alive; early-cycle materials names still have room if you believe EV demand reaccelerates.

Claude’s Top Picks

VOYA (+4.14% today, +8.67% week) — $88.64 → $95.00 (+7.2% upside) Valuation: Trading at a discount to financial services peers given strong earnings across key segments; activist involvement typically closes 15-25% valuation gaps. Upside: Activist pushing for strategic review/sale creates a hard catalyst with a defined timeline — this isn’t “hope” investing, it’s event-driven. Risk: Activist campaigns can fizzle if the board resists or no buyers emerge; the Benefitfocus acquisition concern suggests operational complexity.

GIII (+10.61% today, +10.46% week) — $35.58 → $39.50 (+11.0% upside) Valuation: At RSI 15.33, this was priced for disaster before earnings proved otherwise; the Marc Jacobs deal and margin expansion shift the narrative from value trap to transformation story. Upside: Raised guidance + accretive M&A + gross margin expansion is the trifecta; the stock has 15%+ 90-day return suggesting institutional re-rating is underway. Risk: Apparel is cyclical and tariff-sensitive; the Marc Jacobs deal needs to close cleanly and tariff refund is a one-time benefit.

SFM (+2.13% today, +6.08% week) — $84.58 → $92.00 (+8.8% upside) Valuation: RSI at 4.61 is absurdly oversold for a company growing store count 8% annually with proven same-store sales momentum — this level of pessimism is unwarranted. Upside: New England expansion adds a massive new addressable market; specialty grocery remains a secular share gainer vs. conventional supermarkets. Risk: Kroger’s aggressive price cuts could compress comps; valuation was previously stretched, so this “dip” may just be normalization.

ARCB (+2.65% today, +12.86% week) — $158.90 → $175.00 (+10.1% upside) Valuation: Trucking stocks remain below mid-cycle multiples despite improving fundamentals; raised Q2 guidance mid-quarter is the clearest sign the freight recovery is real. Upside: LTL pricing power returning as capacity tightens; digital platform launch (ArcBest View) adds a recurring revenue narrative. Risk: Freight is notoriously cyclical — if macro deteriorates on Iran escalation or Fed hawkishness, this rolls over fast.

ETR (+5.89% today, +5.02% week) — $110.24 → $119.00 (+7.9% upside) Valuation: Regulated utility with data center growth optionality trading below Barclays’ $119 PT; the utility sector is getting a defensive bid amid geopolitical uncertainty. Upside: AI data center power demand is a multi-year secular tailwind; Entergy’s southern U.S. territory is ground zero for hyperscaler buildouts through 2029. Risk: Morgan Stanley just trimmed PT to $94 — not everyone agrees on the magnitude of the data center benefit; rising rates pressure utility valuations.

Avoid

VSXY (+5.66%, +42.27% weekly) — Up 42% in a single week is a parabolic move regardless of how good the quarter was. Analysts are already calling it “overdone,” and short squeezes reverse violently once covering is complete. Chasing a 42% weekly gainer is how accounts blow up.

OSCR (+6.57%, RSI 67.7) — While the Wells Fargo upgrade is real, the stock already blew past the $20 price target (now at $25.85), meaning the “catalyst” has been fully absorbed. You’re paying 29% above the PT — the easy money is made.

CNK (+3.77%, RSI 68.9) — Record May box office is backward-looking; the question is whether the summer slate sustains it. At RSI nearly 70, this needs to consolidate before offering a good entry. Movie theater stocks have a habit of pumping on blockbuster months then giving it all back.

WSB Sentiment Check

MU — WSB says: BULLISH (80% bullish) Claude says: PARTIALLY AGREE — Memory stocks benefit from the AI capex cycle, and the chip rebound today helps, but MU at 257 mentions means everyone’s already in the trade. When WSB consensus is this lopsided, the easy upside is usually priced in. Wait for a pullback to the 50-day MA rather than buying the open.

MRVL — WSB says: BULLISH (80% bullish) Claude says: AGREE — S&P 500 inclusion is a hard catalyst (index funds forced to buy), and Marvell’s custom silicon for AI hyperscalers is a genuine secular story. This is one of the few WSB favorites with a structural catalyst. The dip was overdone.

MSFT — WSB says: BULLISH (80% bullish) Claude says: AGREE — Microsoft is the safest large-cap AI play with Azure growth reaccelerating and Copilot monetization ramping. In a risk-off geopolitical environment, quality megacaps get flight-to-safety flows. Not exciting, but correct.

NVDA — WSB says: MIXED (55% bullish) Claude says: AGREE WITH MIXED — The split sentiment is appropriate. NVDA’s valuation requires perfection, and with Broadcom getting downgraded and chip sector rotation happening, NVDA may underperform its custom-silicon competitors near-term. It’s not broken, but it’s not the best risk/reward in semis right now.

AVGO — WSB says: BULLISH (80% bullish) Claude says: PARTIALLY DISAGREE — Broadcom just got downgraded, which directly contradicts WSB’s enthusiasm. The 762 upvotes suggest conviction, but fighting a fresh downgrade is risky. Let the downgrade digest for 2-3 days before buying. WSB is often early, which in practice means wrong for the trade horizon they’re playing.

Earnings Scorecard

GIII — BEAT (EPS and margins above guidance) | Stock: +10.61% | Reported: Last week The reaction is justified — raised FY profit guidance plus a transformative acquisition (Marc Jacobs) is a double catalyst. The RSI at 15 pre-earnings meant expectations were basement-low, so the beat has room to continue repricing. Buy-the-breakout, not sell-the-rip.

VSXY — BEAT (double-digit revenue growth, raised annual forecasts) | Stock: +42.27% weekly The reaction is overdone in magnitude even if directionally correct. A 42% weekly move on a retail turnaround prices in 2+ years of execution. Sell-the-rip for anyone who caught the initial move; new buyers should wait for a 15-20% pullback.